Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of D. E. Shaw Research.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
D. E. Shaw Research
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
120 W. 45th St., 39th Fl. New York, NY 10036
Telephone
Telephone
(212) 849-0880
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

DES-7114, is an orally administered, highly selective small-molecule inhibitor of the ion channel protein Kv1.3. It has recently completed Phase 1 clinical trials in healthy volunteers and has demonstrated efficacy in preclinical models of inflammatory and autoimmune diseases.


Lead Product(s): DES-7114

Therapeutic Area: Gastroenterology Product Name: DES-7114

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: Eli Lilly

Deal Size: $535.0 million Upfront Cash: $60.0 million

Deal Type: Licensing Agreement June 13, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY